Precision Medicine trial with the Diabetes Type 1 Vaccine Diamyd®
STOCKHOLM, March 4, 2021 — The upcoming Phase III trial with Diamyd® in new-onset type 1 diabetes will be based on the first precision medicine approach in the field. The trial is…
Hair-like structures in cells of the vessel wall may be relevant for diabetes treatment
A new study from Karolinska Institutet and the Helmholtz Diabetes Research Center shows that primary cilia, hair-like protrusions on endothelial cells inside vessels, play an important role in the blood…